標(biāo)題: Titlebook: Clinical Aspects of Interferons; Michel Revel Book 1988 Kluwer Academic Publishers, Boston 1988 blood.brain tumors.cancer treatment.carcin [打印本頁] 作者: BOUT 時(shí)間: 2025-3-21 20:03
書目名稱Clinical Aspects of Interferons影響因子(影響力)
書目名稱Clinical Aspects of Interferons影響因子(影響力)學(xué)科排名
書目名稱Clinical Aspects of Interferons網(wǎng)絡(luò)公開度
書目名稱Clinical Aspects of Interferons網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Clinical Aspects of Interferons被引頻次
書目名稱Clinical Aspects of Interferons被引頻次學(xué)科排名
書目名稱Clinical Aspects of Interferons年度引用
書目名稱Clinical Aspects of Interferons年度引用學(xué)科排名
書目名稱Clinical Aspects of Interferons讀者反饋
書目名稱Clinical Aspects of Interferons讀者反饋學(xué)科排名
作者: Kidnap 時(shí)間: 2025-3-22 00:04
978-1-4612-8977-7Kluwer Academic Publishers, Boston 1988作者: flammable 時(shí)間: 2025-3-22 03:26 作者: immunity 時(shí)間: 2025-3-22 05:23
Interferon Therapy in Acute Viral Illnessesd spectrum of RNA and DNA viruses, but reports of its use in clinical trials of acute viral infections have been surprisingly meager. There are several reasons for this, the major one being that for the first 20 years after its discovery, stocks were in very short supply, and when available, very expensive.作者: 虛弱 時(shí)間: 2025-3-22 11:36
Clinical Studies of Alpha and Gamma Interferons in Chronic Myelogenous Leukemiaeukemia (CML Ph’). The interferons examined are partially pure alpha interferon, followed by recombinant alpha A interferon (Roche), recombinant gamma interferon, and most recently, combinations of alpha and gamma interferons. Here we summarize what we consider to be the major concepts emerging from those trials.作者: Limerick 時(shí)間: 2025-3-22 13:35
Interferons in Breast Cancerriments showed a possible role for Interferons in treating malignant tumors, phase II trials were activated..A review of the clinical trials applied to the treatment of metastatic breast cancer does not demonstrate any efficiency of Interferon and furthers studies are required.作者: Limerick 時(shí)間: 2025-3-22 18:01
The Role of Beta Interferon in the Treatment of Cervical Dysplasiaby conservative procedures and tissue destruction methods are widely employed. Comparable or even better results in terms of complete remission are obtained with intra-perilesional injection of human fibroblast interferon. The efficacy of interferon is attributed to its antiviral, cytostatic and immunomodulatory properties.作者: 天氣 時(shí)間: 2025-3-22 23:17
The Return of the Symptom in the Postcolony,e recognized as desirable characteristics for use in reratory viral infections (1). In 1973 Merigan . showed that intranasal administration of human leukocyte interferon (HuIFN-α [Le]) in a total dosage of 14 Mu over 4 days reduced seroconversion and illness rates following experimental rhinovirus t作者: Harness 時(shí)間: 2025-3-23 05:07
https://doi.org/10.1007/978-3-476-03986-6nt. The data to be analysed below suggest that, when properly used, interferon offers the combination of efficacy and safety that has not been achieved thus far by any of the other currently available treatments for these two viral infections. However, in order to put this analysis in its proper fra作者: Gerontology 時(shí)間: 2025-3-23 09:30 作者: 駁船 時(shí)間: 2025-3-23 11:14 作者: 光明正大 時(shí)間: 2025-3-23 17:33 作者: TEN 時(shí)間: 2025-3-23 18:58 作者: 脫毛 時(shí)間: 2025-3-23 22:54
Jack Williams B.Sc., D.Sc. (Wales)ion. Although many different biological activities were described, including the elusive interferon, no serious studies with biotherapy were possible because of the poor quality of the biological reagents. All of this changed in the late 1970s with the use of recombinant genetics to produce highly p作者: 說明 時(shí)間: 2025-3-24 05:22 作者: probate 時(shí)間: 2025-3-24 08:47
https://doi.org/10.1007/978-3-031-51116-5ost cases involve a clonal proliferation of B-lymphocytes. The disease is usually stable over months to years and transformation to a more aggressive disease state only rarely occur. More typically the disease slowly evolves to a point where it suppresses the production of normal blood cells leading作者: 不吉祥的女人 時(shí)間: 2025-3-24 14:16 作者: chassis 時(shí)間: 2025-3-24 15:20
,Briefe aus den Jahren 1946–1956,arized various aspects pertinent to IFN therapy of human osteosarcoma. Different experimental approaches are described but we emphasize that IFN treatment should not be used as the primary single treatment in osteosarcoma. Osteosarcoma exerts biological effects which makes it possible to study biolo作者: 領(lǐng)先 時(shí)間: 2025-3-24 19:20
,Beginner’s Panic Guide to Viral Programs,in tumors. Of 46 cases of glioblastoma and malignant astrocytoma treated, satisfactory therapeutic responses were noted in 13 cases (28.3%) and also 3 of 7 cases of medulloblastoma. There was no significant difference in response rate between systemic administration and local (intratumoral or intrat作者: 難理解 時(shí)間: 2025-3-25 01:53
Computer Operations and Viral Operations, severe clinical symptoms such as diarrhoea, flushing, asthma, hypoglycemia, recurrent ulcers, necrolytic migratory erythema and right heart failure (1,2,3,4). The majority of the secretory products from the neuro-endocrine tumors are peptide hormones, but also other substances are released, such as作者: vertebrate 時(shí)間: 2025-3-25 06:00
Poet as Traveler: Lisbon, Madrid, Dublin,by conservative procedures and tissue destruction methods are widely employed. Comparable or even better results in terms of complete remission are obtained with intra-perilesional injection of human fibroblast interferon. The efficacy of interferon is attributed to its antiviral, cytostatic and imm作者: SUGAR 時(shí)間: 2025-3-25 11:18 作者: single 時(shí)間: 2025-3-25 12:10
,Die Verwirrungen des Z?glings T?rle?,d spectrum of RNA and DNA viruses, but reports of its use in clinical trials of acute viral infections have been surprisingly meager. There are several reasons for this, the major one being that for the first 20 years after its discovery, stocks were in very short supply, and when available, very expensive.作者: 打谷工具 時(shí)間: 2025-3-25 19:33 作者: 混合 時(shí)間: 2025-3-25 20:02 作者: 機(jī)密 時(shí)間: 2025-3-26 02:22
Poet as Traveler: Lisbon, Madrid, Dublin,by conservative procedures and tissue destruction methods are widely employed. Comparable or even better results in terms of complete remission are obtained with intra-perilesional injection of human fibroblast interferon. The efficacy of interferon is attributed to its antiviral, cytostatic and immunomodulatory properties.作者: Apraxia 時(shí)間: 2025-3-26 05:04
,The “Preparatory Phase”, 1800–1816,Subacute sclerosing panencephalitis (SSPE) is a progressive fatal central nervous system (CNS) disease affecting children and young adults. Since first described by Dawson in 1933 (1) much knowledge regarding its etiology and pathogenesis, with relation to measles virus, has accumulated, yet there is still no effective treatment.作者: LAPSE 時(shí)間: 2025-3-26 11:02
Jack Williams B.Sc., D.Sc. (Wales)The results of treatment with alpha interferons in more than 90 patients with HCL, treated over the last four years are summarized. Interferon alpha has become an established effective therapy for HCL and has resulted in decreased morbidity and improved prognosis, for patients afflicted with this disorder.作者: Libido 時(shí)間: 2025-3-26 12:40
https://doi.org/10.1007/978-3-031-51116-5The status of systemic therapy for metastatic RCC is reviewed with emphasis on the results of treatment with interferons and its combinations. The use of interferon in RCC represents a modest step forward in the treatment of this highly malignant disease.作者: microscopic 時(shí)間: 2025-3-26 17:39
Use of Interferon in the Treatment of Subacute Sclerosing PanencephalitiesSubacute sclerosing panencephalitis (SSPE) is a progressive fatal central nervous system (CNS) disease affecting children and young adults. Since first described by Dawson in 1933 (1) much knowledge regarding its etiology and pathogenesis, with relation to measles virus, has accumulated, yet there is still no effective treatment.作者: Freeze 時(shí)間: 2025-3-26 22:48 作者: 燕麥 時(shí)間: 2025-3-27 03:11 作者: CRUMB 時(shí)間: 2025-3-27 07:06 作者: NUL 時(shí)間: 2025-3-27 09:29 作者: 靈敏 時(shí)間: 2025-3-27 15:45
Interferon Therapy of Herpes Simplex Dermal Infections and Papillomavirus Condylomatad thus far by any of the other currently available treatments for these two viral infections. However, in order to put this analysis in its proper framework, it will be appropriate to precede it with a short comparative description of the viruses and the diseases caused by them.作者: Anthropoid 時(shí)間: 2025-3-27 19:01
Osteosarcoma Management and Interferonment should not be used as the primary single treatment in osteosarcoma. Osteosarcoma exerts biological effects which makes it possible to study biological parameters extensively. Such a biological approach might lead to an extensive combination treatment schedule and a diversified programme for the treatment of human osteosarcoma patients.作者: 疏忽 時(shí)間: 2025-3-28 00:46 作者: hurricane 時(shí)間: 2025-3-28 05:41 作者: 男學(xué)院 時(shí)間: 2025-3-28 08:19 作者: 值得 時(shí)間: 2025-3-28 12:34
Interferon Therapy of Chronic Lymphocytic Leukemia and Viral Infections in Leukemia Patientspurified alpha interferon preparations have not been active in patients with advanced forms of the disease. However, preliminary results do suggest that low-doses of interferon in early stages of the disease may be efficacious. Interferon alpha has not yet been shown to have a role in the treatment of viral infections associated with leukemia.作者: 吸引人的花招 時(shí)間: 2025-3-28 17:14
,Towards the “New Moral World”, 1816–1825,he syndrome. The rationale for therapeutic trials of interferon alpha, alone or in combination with other antiretroviral agents, to evaluate efficacy in the treatment of the underlying infection with the human immunodeficiency virus is also discussed.作者: Discrete 時(shí)間: 2025-3-28 22:07
Jack Williams B.Sc., D.Sc. (Wales)fferent types of parasitic infections of mammalian hosts. In addition, evidence obtained from . and . experiments will be presented to indicate that interferons could contribute to resistance of hosts to various parasitic infections. The potential for use of interferons in therapy of parasitic diseases will also be discussed.作者: MARS 時(shí)間: 2025-3-29 03:00 作者: 樣式 時(shí)間: 2025-3-29 04:24 作者: 裂隙 時(shí)間: 2025-3-29 07:23
Interferon Treatment of Non-Hodgkin’s Lymphoma and Myeloma: A Model for Biotherapyof these molecules have become available and are now being tested in clinical trials. Thus, rIFN-alpha is a model for the investigation of new biological substances within the fourth modality of cancer treatment, biotherapy (2,3).作者: dyspareunia 時(shí)間: 2025-3-29 13:09 作者: 輕率看法 時(shí)間: 2025-3-29 17:49 作者: 搬運(yùn)工 時(shí)間: 2025-3-29 21:36
Interferon Therapy of Herpes Simplex Dermal Infections and Papillomavirus Condylomatant. The data to be analysed below suggest that, when properly used, interferon offers the combination of efficacy and safety that has not been achieved thus far by any of the other currently available treatments for these two viral infections. However, in order to put this analysis in its proper fra作者: 憤慨點(diǎn)吧 時(shí)間: 2025-3-30 02:24 作者: 壯麗的去 時(shí)間: 2025-3-30 07:52
Kaposi’s Sarcoma and AIDS: The Role of Interferons in Treatmentacteristic infections and neoplasms. This manuscript describes the role of interferons in the treatment of the most common AIDS-associated tumor, Kaposi’s sarcoma, and discusses the potential role of interferons in the treatment or prevention of some of the opportunisitc infections associated with t作者: 娘娘腔 時(shí)間: 2025-3-30 10:34 作者: 左右連貫 時(shí)間: 2025-3-30 12:23 作者: Directed 時(shí)間: 2025-3-30 16:54 作者: 發(fā)誓放棄 時(shí)間: 2025-3-30 22:27 作者: 閑逛 時(shí)間: 2025-3-31 02:57
Interferon Therapy of Chronic Lymphocytic Leukemia and Viral Infections in Leukemia Patientsost cases involve a clonal proliferation of B-lymphocytes. The disease is usually stable over months to years and transformation to a more aggressive disease state only rarely occur. More typically the disease slowly evolves to a point where it suppresses the production of normal blood cells leading作者: assail 時(shí)間: 2025-3-31 09:06
Interferons in Breast Cancerriments showed a possible role for Interferons in treating malignant tumors, phase II trials were activated..A review of the clinical trials applied to the treatment of metastatic breast cancer does not demonstrate any efficiency of Interferon and furthers studies are required.作者: mastopexy 時(shí)間: 2025-3-31 12:59
Osteosarcoma Management and Interferonarized various aspects pertinent to IFN therapy of human osteosarcoma. Different experimental approaches are described but we emphasize that IFN treatment should not be used as the primary single treatment in osteosarcoma. Osteosarcoma exerts biological effects which makes it possible to study biolo作者: Nibble 時(shí)間: 2025-3-31 15:00
Clinical Use of Interferons in the Treatment of Malignant Brain Tumorsin tumors. Of 46 cases of glioblastoma and malignant astrocytoma treated, satisfactory therapeutic responses were noted in 13 cases (28.3%) and also 3 of 7 cases of medulloblastoma. There was no significant difference in response rate between systemic administration and local (intratumoral or intrat作者: Vsd168 時(shí)間: 2025-3-31 21:32
Interferon Treatment of Neuro-Endocrine Tumors of Pancreas and Gut severe clinical symptoms such as diarrhoea, flushing, asthma, hypoglycemia, recurrent ulcers, necrolytic migratory erythema and right heart failure (1,2,3,4). The majority of the secretory products from the neuro-endocrine tumors are peptide hormones, but also other substances are released, such as作者: STRIA 時(shí)間: 2025-4-1 01:40
The Role of Beta Interferon in the Treatment of Cervical Dysplasiaby conservative procedures and tissue destruction methods are widely employed. Comparable or even better results in terms of complete remission are obtained with intra-perilesional injection of human fibroblast interferon. The efficacy of interferon is attributed to its antiviral, cytostatic and imm作者: 尊敬 時(shí)間: 2025-4-1 01:55 作者: 新奇 時(shí)間: 2025-4-1 07:12
